Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,510 | 61 | 91.6% |
| Education | $138.10 | 11 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $865.06 | 29 | $0 (2023) |
| Antares Pharma, Inc. | $137.98 | 2 | $0 (2021) |
| AbbVie, Inc. | $127.18 | 7 | $0 (2018) |
| Astellas Pharma US Inc | $86.44 | 2 | $0 (2019) |
| Lilly USA, LLC | $65.84 | 4 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $52.82 | 4 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.33 | 3 | $0 (2017) |
| PFIZER INC. | $43.00 | 3 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $36.97 | 5 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $36.21 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $63.17 | 2 | Janssen Pharmaceuticals, Inc ($44.22) |
| 2021 | $262.53 | 3 | Antares Pharma, Inc. ($137.98) |
| 2020 | $113.23 | 2 | Janssen Pharmaceuticals, Inc ($113.23) |
| 2019 | $329.20 | 12 | Janssen Pharmaceuticals, Inc ($236.53) |
| 2018 | $98.81 | 5 | Janssen Pharmaceuticals, Inc ($58.90) |
| 2017 | $781.03 | 48 | Janssen Pharmaceuticals, Inc ($287.63) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Respiratory | ||||||
| 09/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $44.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $128.92 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 06/22/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 02/25/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $105.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/18/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $7.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/09/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Education | In-kind items and services | $5.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/22/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $7.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $75.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $7.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $35.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/14/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Education | In-kind items and services | $6.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $62.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 11/19/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Respiratory | ||||||
| 10/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Virology | ||||||
| 10/05/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 569 | 1,295 | $452,837 | $76,335 |
| 2022 | 14 | 810 | 1,678 | $505,804 | $89,151 |
| 2021 | 15 | 1,084 | 2,025 | $565,744 | $117,075 |
| 2020 | 11 | 1,076 | 2,069 | $514,655 | $90,847 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 250 | 758 | $357,695 | $58,581 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 241 | $76,839 | $13,644 | 17.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $2,112 | $1,582 | 74.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 95 | $10,355 | $849.64 | 8.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 41 | 90 | $2,549 | $752.24 | 29.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $2,139 | $670.91 | 31.4% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 13 | $671.00 | $139.52 | 20.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 53 | $477.00 | $114.41 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 300 | 807 | $362,721 | $61,646 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 338 | $102,163 | $19,226 | 18.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 35 | $2,854 | $2,249 | 78.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 65 | 134 | $13,973 | $1,192 | 8.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $7,516 | $964.18 | 12.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 35 | $3,099 | $955.64 | 30.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 16 | 18 | $3,114 | $765.02 | 24.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 32 | 44 | $2,996 | $646.96 | 21.6% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 53 | 128 | $2,854 | $527.67 | 18.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 21 | 39 | $1,088 | $318.67 | 29.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 14 | 14 | $1,393 | $197.96 | 14.2% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 11 | 11 | $966.00 | $184.12 | 19.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 11 | 11 | $590.00 | $159.19 | 27.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 35 | 53 | $477.00 | $117.96 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 313 | 847 | $362,541 | $71,388 | 19.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 228 | 447 | $129,052 | $26,797 | 20.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 55 | 55 | $4,290 | $3,524 | 82.1% |
About Dr. Barry Scanlan, DO
Dr. Barry Scanlan, DO is a Internal Medicine healthcare provider based in Dallas, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497712277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Scanlan, DO has received a total of $1,648 in payments from pharmaceutical and medical device companies, with $63.17 received in 2023. These payments were reported across 72 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,510).
As a Medicare-enrolled provider, Scanlan has provided services to 3,539 Medicare beneficiaries, totaling 7,067 services with total Medicare billing of $373,407. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dallas, NC
- Active Since 04/27/2006
- Last Updated 03/09/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497712277
Products in Payments
- XARELTO (Drug) $589.02
- INVOKANA (Drug) $270.02
- XYOSTED (Drug) $137.98
- Viekira (Drug) $61.00
- JARDIANCE (Drug) $55.17
- Androgel (Drug) $45.68
- TRADJENTA (Drug) $45.11
- Amitiza (Drug) $27.99
- Oralair (Drug) $26.94
- ANORO (Drug) $23.94
- TOUJEO (Drug) $22.14
- Mavyret (Drug) $20.50
- LONHALA MAGNAIR (Drug) $19.41
- BREZTRI (Drug) $18.95
- EUCRISA (Drug) $17.68
- FARXIGA (Drug) $15.97
- ENTRESTO (Drug) $15.71
- SOLIQUA (Drug) $14.07
- STIOLTO (Drug) $13.89
- ELIQUIS (Drug) $13.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dallas
Andrew Whiteley
Internal Medicine — Payments: $1.7M
Biff Palmer, Md, MD
Internal Medicine — Payments: $980,569
Dr. Robert Gottlieb, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $832,284
Dr. Ronan Kelly, Md, MD
Internal Medicine — Payments: $813,092
Dr. Gates Colbert, M.d, M.D
Internal Medicine — Payments: $801,349
Dr. Zoran Kurepa, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $743,379